Minami, T., Kijima, T., Kohmo, S., Arase, H., Otani, Y., Nagatomo, I., et al. (2013) Overcoming Chemoresistance of Small-Cell Lung Cancer through Stepwise HER2-Targeted Antibody-Dependent Cell-Mediated Cytotoxicity and VEGF-Targeted Antiangiogenesis. Scientific Reports, 3, 2669. http://dx.doi.org/10.1038/srep02669

has been cited by the following article:

• TITLE: Missing the Target?—Targeted Therapy in Small Cell Lung Cancer

  AUTHORS: Karin R. Purshouse

  KEYWORDS: Oncology, Small Cell Lung Cancer, Targeted Therapy, Drug Development

  JOURNAL NAME: Advances in Lung Cancer, Vol.3 No.3, August 22, 2014

  ABSTRACT: Small cell lung cancer [SCLC] is a devastating form of cancer, with most patients harbouring extensive disease at diagnosis and survival of less than 5% at five years. Progress in novel therapies has been limited. This specialist review explores current targeted therapy options and potential areas of development.